CTI BioPharma
CTIC
#5622
Rank
NZ$2.07 B
Marketcap
NZ$15.73
Share price
0.00%
Change (1 day)
33.17%
Change (1 year)

Market capitalization of CTI BioPharma (CTIC)

Last known market cap: NZ$2.07 Billion

On August 25, 2023 CTI BioPharma had a market cap of NZ$2.07 Billion. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of CTI BioPharma from 2001 to 2023

End of year Market Cap

Year Marketcap Change
2023NZ$1.89 B57.81%
2022NZ$1.20 B242.15%
2021NZ$0.35 B3.65%
2020NZ$0.33 B149.01%
2019NZ$0.13 B114.49%
2018NZ$63.41 M-60.89%
2017NZ$0.16 B-2.39%
2016NZ$0.16 B-67.04%
2015NZ$0.50 B-5.33%
2014NZ$0.53 B57.43%
2013NZ$0.33 B94.87%
2012NZ$0.17 B-39.42%
2011NZ$0.28 B-25.58%
2010NZ$0.38 B-58.45%
2009NZ$0.92 B6468.7%
2008NZ$14.1 M-88.82%
2007NZ$0.12 B-64.89%
2006NZ$0.35 B56.81%
2005NZ$0.22 B-67.09%
2004NZ$0.69 B53.55%
2003NZ$0.45 B-0.15%
2002NZ$0.45 B-76.85%
2001NZ$1.96 B

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Amgen
AMGN
NZ$307.49 B 14,718.23%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$183.77 B 8,755.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$34.83 B 1,578.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
NZ$16.49 B 695.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$1.567 T 75,451.17%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
NZ$56.52 B 2,623.72%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Novartis
NVS
NZ$438.96 B 21,053.64%๐Ÿ‡จ๐Ÿ‡ญ Switzerland